Zimmer Biomet Holdings (ZBH) Cash from Operations Growth (1y) (2010 - 2026)
Zimmer Biomet Holdings (ZBH) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn | -84.38% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 185.96% |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn | 16.00% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn | 122.43% |
| 10 | Zimmer Biomet Holdings | 18.03 Bn | 17.61 Bn | 1.51 Bn | -6.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.11% |
| Dec 31, 2025 | 2.19% |
| Sep 30, 2025 | 5.81% |
| Jun 30, 2025 | 2.38% |
| Mar 31, 2025 | 67.89% |
| Dec 31, 2024 | -13.95% |
| Sep 30, 2024 | 17.21% |
| Jun 30, 2024 | 6.18% |
| Mar 31, 2024 | -25.90% |
| Dec 31, 2023 | 140.95% |
| Sep 30, 2023 | -25.11% |
| Jun 30, 2023 | 0.69% |
| Mar 31, 2023 | -2.53% |
| Dec 31, 2022 | -27.67% |
| Sep 30, 2022 | 6.27% |
| Jun 30, 2022 | -17.54% |
| Mar 31, 2022 | 41.25% |
| Dec 31, 2021 | 13.98% |
| Sep 30, 2021 | 11.25% |
| Jun 30, 2021 | 893.56% |